This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Hélène Tran, Ph.D.
Oligo Therapeutics Program Science Lead at Servier


Dr Hélène Tran built and is currently leading the oligonucleotide therapeutic platform in Servier, France; dedicated to develop and optimize antisense oligonucleotide therapies for the treatment of fatal neurological disorders. Prior to Servier, Hélène worked in academic laboratories on RNA mediated disorders in France and in US. Her work at Umass Medical School in the Neurology department lead by Pr. Robert Brown with whom she developed ASO therapies also contributed to better understand disease biology of amyotrophic lateral sclerosis.

Agenda Sessions

  • Oligonucleotide Therapies for Rare Neurological Diseases